valsartan has been researched along with Takotsubo Cardiomyopathy in 4 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 2 (50.00) | 24.3611 |
2020's | 2 (50.00) | 2.80 |
Authors | Studies |
---|---|
Bachórzewska-Gajewska, H; Dobrzycki, S; Zalewska-Adamiec, M | 1 |
Chen, YH; Lai, HC; Lee, WL; Liu, TJ | 1 |
Dissanayake, DPS; Lim, SL; Ong, CC; Tay, SH; Teo, LLS | 1 |
Peters, S | 1 |
4 other study(ies) available for valsartan and Takotsubo Cardiomyopathy
Article | Year |
---|---|
The use of sacubitril / valsartan in Takotsubo syndrome with severe impairment of left ventricular systolic function.
Topics: Heart Failure; Humans; Takotsubo Cardiomyopathy; Treatment Outcome; Valsartan; Ventricular Function, Left | 2023 |
Iatrogenic Takotsubo Cardiomyopathy Following Overdose Norepinephrine Administration During Percutaneous Coronary Intervention.
Topics: Adrenergic beta-1 Receptor Antagonists; Angiotensin II Type 1 Receptor Blockers; Bisoprolol; Coronary Restenosis; Creatine Kinase; Creatine Kinase, MB Form; Drug Overdose; Drug-Eluting Stents; Echocardiography; Humans; Hypotension; Iatrogenic Disease; Intra-Aortic Balloon Pumping; Intraoperative Complications; Male; Medication Errors; Middle Aged; Norepinephrine; Percutaneous Coronary Intervention; Recovery of Function; Shock, Cardiogenic; Stents; Stroke Volume; Takotsubo Cardiomyopathy; Troponin I; Valsartan; Vasoconstrictor Agents | 2020 |
Takotsubo and Takayasu-A Reason to Rhyme?
Topics: Angiotensin II Type 1 Receptor Blockers; Computed Tomography Angiography; Cyclophosphamide; Echocardiography; Female; Glucocorticoids; Humans; Immunosuppressive Agents; Magnetic Resonance Imaging; Middle Aged; Prednisolone; Takayasu Arteritis; Takotsubo Cardiomyopathy; Valsartan | 2019 |
Stress-related takotsubo cardiomyopathy despite "optimal" medical therapy.
Topics: Aged; Aminobutyrates; Biphenyl Compounds; Drug Combinations; Dyspnea; Female; Humans; Stress, Physiological; Takotsubo Cardiomyopathy; Tetrazoles; Treatment Outcome; Valsartan | 2016 |